yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
2
Q33667485-4F32FB28-FC16-405D-8F13-67515F1845F0
Q33667485-4F32FB28-FC16-405D-8F13-67515F1845F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33667485-4F32FB28-FC16-405D-8F13-67515F1845F0
Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.
P2860
Q33667485-4F32FB28-FC16-405D-8F13-67515F1845F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33667485-4F32FB28-FC16-405D-8F13-67515F1845F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966fd4d5bb829180786fe2c8a77cc8056d79c901
P2860
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr